John Gilroy (Labour)

I appreciate the protection the Chair is giving me from the unreasonable heckling from the other side of the House, which seems to possess the totality of knowledge on this matter. Section 3 seems to allow all "medicinal products necessary for the treatment of cancer, as approved by the European Medicines Agency" to be prescribed by a "registered medical practitioner". I suggest this is at variance with best practice. It is likely that it would be done without the benefit of multidisciplinary assessment and support. Therefore, it would probably not be in the best interests of patients. Section 3 refers to the approval by the European Medicines Agency of "products necessary for the treatment of cancer". The agency approves new drugs for sale but it does not-----